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cowadays,  patients  with  AIDS  can  live  a  life  with  consider-
ble  quality  in  relation  to  oral  health,  being  healthy  enough
o  tolerate  most  surgical  and  dental  procedures.  Further-
ore,  several  studies  have  shown  that  patients  with  HIV
isease  are  not  more  susceptible  to  complications,  regard-
ess  of  CD4-cell  counts.
There  are  no  oral  lesions  that  are  speciﬁc  to  HIV  patients.
ll  lesions  found  among  HIV-positive  patients  also  occur  in
ther  diseases  associated  with  immunosuppression.  Thus,
e  conclude  that  there  is  a  clear  correlation  between  the
nset  of  oral  lesions  and  decreases  in  the  immune  system.
everal  lesions,  such  as  oral  thrush,  hairy  leukoplakia,  ulcer-
tive  necrotizing  periodontal  disease  and  Kaposi’s  sarcoma
re  strongly  suggestive  of  impaired  immune  response,  with
D4  counts  below  200  cells/mm3.  If  we  consider  oral  lesions
s  markers  of  immunosuppression  and  progression  of  AIDS,
t  may  play  a  role  in  intervention  strategies  and  treatment.
We  can  cite  as  major  oral  lesions  of  patients  with  HIV:
ungal infections
andidiasis: Caused  primarily  by  Candida  albicans,  it  is  the
ost  frequent  oral  manifestation.  Although  not  being,  by
tself,  pathognomonic  of  AIDS,  oral  candidiasis  may  be  an
ndication  of  immunosuppression  and  disease  progression.
Angular  cheilitis:  Mixed  infection  involving  C.  albicans
nd  Staphylococcus  aureus, manifests  itself  as  red  cracks
ith  origin  from  the  labial  commissure  of  the  mouth,
nd  may  be  present  along  with  intraoral  candidiasis.  The
oncomitant  occurrence  of  dry  mouth  is  not  an  uncommon
oﬁnding.
The  treatment  of  oral  candidiasis  includes  topical  and
ystemic  antifungal  medication.  Topical  therapies  include
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eserved.opical  antifungal  mouthwash,  tablets  and  oral  gel.  These
ormulations  should  be  used  concomitantly  with  systemic
rugs,  especially  in  cases  of  esophageal  candidiasis.  Top-
cal  antifungal  therapies  are  more  effective  in  patients
ith  CD4  counts  over  150--200  cells/mm3. Common  topical
reatments  are  nystatin  oral  suspension  (100,000  units/mL),
ystatin  tablets,  and  oral  gel,  for  example,  miconazole
nd  clotrimazole  1%.  The  most  common  systemic  antifun-
al  agents  are  ﬂuconazole  (150-mg  tablets)  and  itraconazole
00  mg.  Resistance  to  ﬂuconazole  was  reported  as  occurring
n  patients  with  severe  immune  deﬁciency.
Treatments  of  ﬂuconazole-resistant  patients  with  a
ombination  of  ﬂuconazole  and  terbinaﬁne  have  been  suc-
essful.
eep infections
ntraoral  manifestations  caused  by  Cryptococcus  neofor-
ans,  Histoplasma  capsulatum, Geotrichum  candidum  and
spergillus  spp.  are  uncommon  and  generally  suggest
 signiﬁcant  immunosuppression.  Disseminated  intraoral
esions  associated  with  cryptococcosis,  histoplasmosis  and
spergillosis  were  described  as  ulcerative  and  nodular
vents,  while  geotrichosis  lesions  are  described  as  pseu-
omembranous  events.  As  the  oral  lesions  in  this  category
re  non-speciﬁc,  the  deﬁnitive  diagnosis  requires  histolog-
cal  veriﬁcation.  In  general,  the  treatment  of  these  lesions
onsists  in  intravenous  amphotericin  B.
iral infections
lthough  there  are  no  speciﬁc  oral  lesions  caused  by  HIV
nfection,  patients  may  exhibit  oral  manifestations  as  an
arly  sign  of  HIV  infection.1 Such  symptoms  include  non-
peciﬁc  oral  ulcers,  pharyngitis  and  oral  candidiasis  during
he  acute  phase  of  infection.
ia Cérvico-Facial. Published by Elsevier Editora Ltda. All rights
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Herpes virus (HSV)
In  general,  the  presence  of  intraoral  lesions  by  HSV  is  the
result  of  the  reactivation  of  a  latent  virus,  and  among
immunocompromised  individuals,  this  condition  can  be  more
severe,  with  a  diverse  manifestation.  Although  ulcers  caused
by  HSV-1  and  HSV-2  are  clinically  indistinguishable,  in  the
oral  cavity  HSV  manifest  in  the  form  of  vesicles  with  ulcer-
ation,  with  subsequent  healing.  These  are  small,  shallow
ulcers,  and  tend  to  be  healed  in  7--10  days,  although  this
period  may  be  extended  in  immunocompromised  patients.
Patients  may  present  clinical  signs  and  symptoms  that
resemble  those  of  a  primary  HSV  infection,  such  as  malaise
and  an  intensely  painful  cervical  lymphadenopathy.
Differential  diagnosis  should  include  other  viral  infec-
tions,  such  as  cytomegalovirus,  varicella  zoster,  and
aphthous  ulcers.  The  diagnosis  should  be  based  on  clinical
history  and  laboratory  tests  (cytological  staining  for  Tzanck
cells,  viral  culture  of  the  ulcer,  biopsy,  or  presence  of  anti-
body).  Treatment  includes  acyclovir  and  famciclovir  (can
cause  side  effects  in  immunocompromised  patients).  Fos-
carnet  can  be  used  for  resistant  infections.
Cytomegalovirus (CMV)
Oral  manifestation  of  cytomegalovirus  (CMV)  is  observed
only  in  patients  with  CD4  counts  below  100  cells/mm3 in
the  disseminated  form  of  the  disease.  The  lesions  associ-
ated  with  CMV  are  non-speciﬁc  ulcerations  in  any  area  of  the
oral  mucosa.  The  differential  diagnosis  should  include  recur-
rent  aphthous  ulcers  and  HSV.  A  deﬁnitive  diagnosis  should
include  a  biopsy  revealing  intranuclear  inclusions  of  CMV  in
basophils,  or  on  the  identiﬁcation  by  monoclonal  antibody
assay.  As  a  therapeutic  regimen,  acyclovir  may  be  given  in
high  doses  (800  mg  PO  5×/day)  for  a  minimum  period  of  two
weeks.
Epstein--Barr virus (EBV)
Various  manifestations  may  be  related  to  EBV,  such  as
mononucleosis,  Burkitt’s  lymphoma,  nasopharyngeal  carci-
noma  and  oral  hairy  leukoplakia.  Oral  hairy  leukoplakia  was
initially  described  as  a  pathognomonic  lesion  of  AIDS,  but
this  condition  has  been  diagnosed  in  many  other  diseases.
Hairy  leukoplakia  may  be  present  at  all  stages  of  HIV  disease,
but  this  condition  is  more  commonly  found  in  patients  with
CD4  counts  below  200  cells/mm3.  Leukoplakia  manifests  as
a  white  lesion  in  the  form  of  hyperkeratotic  vertical  streaks
on  the  side  margins  of  the  tongue.
Usually,  there  is  no  need  to  treat  this  injury,  unless  the
patient  complains  of  his/her  injury,  either  esthetically  or
for  some  functional  impairment.  Antiviral  therapy  (acyclovir
800  mg  PO  5×/day)  is  effective  in  achieving  resolution.
Varicella-Zoster virusThere  are  reports  of  increased  incidence  of  human  varicella-
zoster  virus  (HZV)  among  HIV-infected  patients.  This
occurrence  is  common  and  can  be  severe,  especially  for
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hose  individuals  with  CD4  counts  below  200  cells/mm3.
linically,  the  oral  lesion  presents  in  the  form  of  vesicles
hich  rupture  quickly,  forming  multiple  shallow  ulcerations
ith  an  erythematous  base,  distributed  along  a  unilat-
ral  division  of  ﬁfth  cranial  nerve.  Patients  often  complain
bout  severe  pain.  Laboratory  tests:  Histological  staining
or  giant  cells  with  intranuclear  inclusions,  direct  immuno-
uorescence  and  cytology.  Generally,  the  treatment  consists
n  supporting  and  preventing  from  postherpetic  neuralgia,
onsisting  of  high-dose  acyclovir  (800  mg  PO  5×/day),  fam-
iclovir  (500  mg  PO  3×/day),  or  valacyclovir  (500  mg  PO
×/day).
uman papillomavirus (HPV)
ral  manifestations  of  papillomavirus  may  present  different
eatures,  including:  verruca  vulgaris,  focal  epithelial  hyper-
lasia  and  condyloma  acuminatum.  The  presence  of  HPV
esions  is  not  pathognomonic  of  HIV  infection.2
Cosmetic  treatments  for  HPV  include  surgical  removal,
aser  ablation,  cryotherapy,  and  topical  application  of  ker-
tinolytic  agents.  The  use  of  intralesional  injection  of
ntiviral  agents,  for  instance,  injection  (1,000,000  IU/cm2,
×/week)  and  subcutaneous  (3,000,000  IU/cm2,  2×/week)
nterferon-,  demonstrated  efﬁcacy  in  long-term  resolution.
aposi’s sarcoma (KS)
aposi’s  sarcoma  lesions  are  found  in  the  soft  palate,  in  the
orm  of  red-blue  or  purple-blue  color  maculae,  or  in  the
orm  of  nodules.  Initially,  the  lesions  are  asymptomatic,  but
ue  to  minor  traumas  and  ulcerations,  may  become  symp-
omatic  for  speaking  and  chewing.  Lesions  on  the  gums  and
ongue  are  also  common.  Extrapalatal  lesions  are  associated
ith  a  quick  progression  of  AIDS.  These  injuries  usually  occur
n  patients  with  CD4  counts  below  200  cells/mm3, but  can
e  observed  at  all  stages  of  disease.  Differential  diagnosis
ith  physiologic  pigmentation:  bacillary  angiomatosis,  lym-
homa  and  trauma.  For  the  deﬁnitive  diagnosis,  a  biopsy
s  required.  Treatment  for  SK  consists  of  radiation,  surgi-
al  excision,  and  intralesional  injections  of  an  appropriate
hemotherapeutic  agent.  It  is  important  to  realize  that  most
f  these  treatments  are  not  curative,  but  they  are  pre-
cribed  to  reduce  the  size  and  number  of  lesions.  Recent
tudies  have  shown  some  efﬁcacy  with  antiangiogenesis
gents,  such  as  thalidomide  and  retinoic  acid.
acterial infection: periodontal disease
ral  manifestations  of  bacterial  origin  are  associated  with
eriodontal  conditions  and  can  be  classiﬁed  as:  linear  gingi-
al  erythema  (LGE),  necrotizing  ulcerative  gingivitis  (NUG)
nd  necrotizing  ulcerative  periodontitis  (NUP).
It  was  also  observed  that  HIV-seropositive  patients  and
ith  prior  periodontal  disease  may  exhibit  faster  rates  of
eriodontal  deterioration.
The  differential  diagnosis  should  include  erythema  due
o  a  dry  mucosa  in  association  with  mouth  breathing,  lichen
lanus,  mucosal  pemphigoid,  or  an  allergic  reaction.
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Such  manifestations  may  be  associated  with  subgingival
andidiasis  as  a  possible  cause.  The  treatment  consists  in
ral  health  care  improvement  and  use  of  topical  antifungals.
Manifestations  of  NUG  and  NUP  are  triggered  by  changes
n  the  immune  status,  more  likely  aggravated  by  bacteria,
tress,  anxiety,  malnutrition  and  smoking.
Deﬁnite  diagnosis  is  based  on  a  clinical  workup  and
adiological  evaluation,  with  panoramic  or  periapical  radio-
raphs.  There  may  be  need  for  speciﬁc  laboratory  tests  for
xclusion  of  the  following  conditions  and  injuries,  among
thers:  bullous  lesions  of  benign  mucosal  pemphigoid,  ery-
hema  multiforme,  acute  forms  of  leukemia  and  major-type
phthous  ulcerations.  The  treatment  for  both  conditions
onsists  in  debridement  of  necrotic  soft  and  hard  tissues
nd  antibiotic  therapy.
uberculosis (TB)
ntraoral  lesions  associated  with  TB  may  present  as  painful
ranulomatous  ulcerations,  mainly  on  the  tongue  and
alate.  The  clinical  diagnosis  is  difﬁcult,  and  tubercle  bacilli
urvey  and  an  assessment  of  the  airways  (lung  and  larynx)
re  required.
yphilis
he  clinical  presentation  of  syphilis  includes  cankers,  ulcers
nd  plates.  Cankers  are  indurated  ulcers  which,  in  most
ases,  are  asymptomatic  and  often  seen  on  the  lips,  oral
ucosa,  tongue,  palate  and  posterior  pharyngeal  wall.  The
econdary  injury  is  characterized  by  mucosal  ulcers  or
laques  with  an  opalescent  white  lesion  aspect.  The  dif-
erential  diagnosis  should  include  cold  sores,  deep  fungal
nfections,  ulcers  associated  with  mycobacteria,  malignant
lcers  and  trauma.  The  deﬁnitive  diagnosis  is  done  by  dark
eld  microscopy,  demonstrating  Treponema  pallidum.  Treat-
ent  is  with  systemic  antibiotics.
onspeciﬁc ulcers
ecrotizing  stomatitis  is  an  acute  painful  ulcerative  lesion  in
ucosal  surfaces,  leading  to  tissue  necrosis  and  subsequent
one  exposure.  No  speciﬁc  microbial  agent  or  mechanism
as  been  associated  with  its  etiology.  This  condition  is  seen
n  patients  with  CD4  counts  below  100  cells/mm3.  The  dif-
erential  diagnosis  includes  aphthous  ulceration  and  NUP.
reatment  involves  a  careful  debridement  and  therapy  with
teroids  and  antibiotics.
phthous ulcerations
ecurrent  aphthous  ulcerations  (RAUs)  are  idiopathic  oral
lcerations.  Clinical  presentations:  minor,  major  and  her-
etiformis  RAU.  This  is  a  diagnosis  of  exclusion.  Its  duration
s  about  1--2  weeks,  being  healed  without  scarring.  Minor
phthous  ulcerations  are  also  prevalent  in  HIV-infected  and
ninfected  populations.  Major  aphthous  ulcers  can  occur
n  any  area  of  the  oral  mucosa  and  tend  to  persist  for
ore  than  three  weeks,  being  healed  with  scar  formation.
C
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n  HIV-infected  patients,  aphthous  ulcerations  have  been
ssociated  with  severe  immunosuppression,  with  CD4  counts
elow  100  cells/mm3,  being  markers  of  HIV  disease  pro-
ression.  Treatment  for  major  aphthous  ulcerations  includes
ystemic  corticosteroids.  Topical  formulations  of  clobeta-
ol  or  dexamethasone  elixir  (0.5  mg/5  mL)  and  the  systemic
dministration  of  prednisone  60--80  mg/day  for  10  days  were
sed  with  success.  For  corticosteroid-resistant  patients,  an
lternative  therapy  with  thalidomide  100--200  mg  may  be
ffective.  Colchicine  or  levamisole  are  alternatives.
lceration induced by medication
everal  drugs  frequently  used  for  patients  with  HIV
nfection  have  been  associated  with  the  development
f  ulcerations:  zidovudine,  zalcitabine,  foscarnet,  inter-
eron  and  ganciclovir.  Certain  antiretroviral  therapies  can
nduce  neutropenia  and  subsequent  occurrence  of  oral
lcerations.
erostomia
erostomia  or  dry  mouth  is  a  symptom  frequently  observed
n  HIV-infected  patients.  It  has  been  reported  that  reduced
alivary  ﬂow  occurs  in  2--30%  of  subjects.  The  most  com-
on  cause  of  reduced  salivary  ﬂow  is  due  to  the  side
ffects  of  medication,  for  example,  anti-retroviral  agents
including  nucleoside  transcriptase  inhibitors,  protease
nhibitors),  as  well  as  antihistamines,  anticholinergics,  anti-
ypertensive  agents,  decongestants,  narcotic  analgesics,
nd  tricyclic  antidepressants.  Furthermore,  xerostomia
an  result  from  a  salivary  gland  disease  associated  with
IV.
The  parathyroid  glands  are  more  frequently  affected;
owever,  minor  salivary  glands  may  also  be  affected  by  a
iral  infection,  for  example,  CMV.
The  treatment  for  xerostomia  focuses  on  symptomatic
elief  through  hydration,  minimizing  the  consumption  of
lcohol  and  caffeine,  and  using  artiﬁcial  saliva.  The  use  of
ilocarpine  to  stimulate  saliva  ﬂow  may  be  a  useful  option.
inal considerations
t  is  important  to  recognize  the  oral  lesions  of  patients  with
IV,  both  by  otorhinolaryngologists  and  by  our  residents  who
ad  no  contact  with  these  patients  in  the  years  80--90,  when
iagnosis  was  often  obtained  through  these  injuries.  Even
oday,  despite  the  effectiveness  of  therapeutic  programs
nd  of  drug  efﬁcacy,  a large  number  of  individuals  exist  who
re  unaware  that  they  are  infected,  and  thereby  the  disease
an  develop  at  any  particular  time.  In  addition,  at  outpatient
linics  we  have  seen  patients  who  neglect  or  refuse  treat-
ent,  and  again  show  these  lesions  without  revealing  thatonﬂicts of  interest
he  author  declares  no  conﬂicts  of  interest.
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